Sandoz Group AG (MEX:SDZN) EBIT: MXN26,201 Mil (TTM As of Dec. 2025)


MEX:SDZN Sandoz Group AG MEX:SDZN
16 GF Score
Price MXN1,481.70
! 6 Warning Signs
View Full Analysis

What is Sandoz Group AG EBIT?

Sandoz Group AG MEX:SDZN 16 EBIT is MXN26,201 Mil as of Dec. 2025. GuruFocus rates MEX:SDZN with a GF Score™ of 16/100. The stock has 6 warning signs investors should review.

Sandoz Group AG's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was MXN14,621 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was MXN26,201 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Sandoz Group AG's annualized ROC % for the quarter that ended in Dec. 2025 was 6.89%. Sandoz Group AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 54.58%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Sandoz Group AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 3.54%.

Sandoz Group AG  (MEX:SDZN) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Sandoz Group AG's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=29637.382 * ( 1 - 23.61% )/( (336628.437 + 321005.62)/ 2 )
=22639.9961098/328817.0285
=6.89 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=406917.841 - 44135.645 - ( 26153.759 - max(0, 121956.728 - 157675.721+26153.759))
=336628.437

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=396701.583 - 52828.724 - ( 31311.912 - max(0, 124149.302 - 147016.541+31311.912))
=321005.62

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Sandoz Group AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=29241.256/( ( (43872.036 + max(13218.099, 0)) + (50055.846 + max(-1062.336, 0)) )/ 2 )
=29241.256/( ( 57090.135 + 50055.846 )/ 2 )
=29241.256/53572.9905
=54.58 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(43570.769 + 57937.448 + 30013.745) - (44135.645 + 0 + 74168.218)
=13218.099

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(45158.296 + 51226.217 + 14584.617) - (52828.724 + 0 + 59202.742)
=-1062.336

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Sandoz Group AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=26200.586/741116.085
=3.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sandoz Group AG EBIT Related Terms

Sandoz Group AG EBIT Historical Data

* Premium members only.

The historical data trend for Sandoz Group AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sandoz Group AG EBIT Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23 Dec24 Dec25
EBIT
23,219.74 5,635.45 5,005.37 25,694.13

Sandoz Group AG Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial -1,510.71 6,045.63 -1,877.01 11,579.96 14,620.63

MEX:SDZN vs ZTS, UTHR, VTRS: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sandoz Group AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sandoz Group AG EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sandoz Group AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sandoz Group AG's EV-to-EBIT falls into.


MEX:SDZN
16GF Score
Sandoz Group AG MEX:SDZN
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sandoz Group AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was MXN26,201 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of MXN26,201 Mil mean?
Sandoz Group AG (MEX:SDZN) has a EBIT of MXN26,201 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Sandoz Group AG.
Is Sandoz Group AG's EBIT too high?
Sandoz Group AG's current EBIT is MXN26,201 Mil. Overall, Sandoz Group AG has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Sandoz Group AG's EBIT compare to ZTS and UTHR?
Sandoz Group AG's EBIT of MXN26,201 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Sandoz Group AG. Sandoz Group AG's current EBIT is MXN26,201 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sandoz Group AG stock overvalued right now?
Sandoz Group AG (MEX:SDZN) has a current EBIT of MXN26,201 Mil. The current EBIT is MXN26,201 Mil. Sandoz Group AG's overall GF Score™ is 16/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Sandoz Group AG (MEX:SDZN), the current EBIT is MXN26,201 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sandoz Group AG Business Description

Address Centralbahnstrasse 4, Basel, CHE, 4051
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $11 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among the leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006, as well as the first US biosimilar, Zarxio, in 2015. It has over 10 launched biosimilars in a number of markets and over 20 assets in its pipeline.
16GF Score

Get the complete analysis for MEX:SDZN

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,481.70
Price